| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |